No open-market buying or selling by insiders.
No executive or director has bought shares on the open market in the last two years.
Get an email when QUCY's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | Kevin Michael Donahue Large holder | Bought | 685,000 | $1.51 | $1.03M | New | Form 4 |
- Oct 17, 2025Kevin Michael DonahueLarge holder · bought 685,000 at $1.51$1.03MNew position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with QUCY
Spot a number that looks wrong? Check it in QUCY's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing QUCY
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.